FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay to Include COVID-19 Testing of Asymptomatic Individuals

Share, email, print, bookmark SOURCE reports.

MARLBOROUGH – Hologic, Inc. announced today, October 6, its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from

Read more